Zimmer Biomet Holdings, Inc.
94.61USD
+0.3900 (+0.41%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,177 | 2,087 | 2,244 | 2,001 | 2,077 | 1,909 | 2,023 | 1,824 |
| Cost of Revenue | 636 | 576 | 792 | 559 | 592 | 550 | 587 | 539 |
| Gross Profit | 1,542 | 1,511 | 1,451 | 1,442 | 1,485 | 1,359 | 1,437 | 1,286 |
| Operating Income | 326 | 373 | 155 | 351 | 300 | 292 | 389 | 280 |
| Net Income | 198 | 238 | 139 | 231 | 153 | 182 | 240 | 249 |
| EPS (Diluted) | $1.03 | $1.22 | $0.71 | $1.16 | $0.77 | $0.91 | $1.19 | $1.23 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)